Neoadjuvant dual HER2-targeted therapy with lapatinib and trastuzumab improves pathologic completeresponse in patients with early stage HER2-positive breast cancer: A meta-analysis of randomized prospective clinical trials

Mellissa Hicks, Erin R. Macrae, Mahmoud Abdel-Rasoul, Rachel Layman, Susan Friedman, Jenny Querry, Maryam Lustberg, Bhuvaneswari Ramaswamy, Ewa Mrozek, Charles Shapiro, Robert Wesolowski

Research output: Contribution to journal › Article › peer-review

42 Scopus citations

Fingerprint

Dive into the research topics of 'Neoadjuvant dual HER2-targeted therapy with lapatinib and trastuzumab improves pathologic completeresponse in patients with early stage HER2-positive breast cancer: A meta-analysis of randomized prospective clinical trials'. Together they form a unique fingerprint.

Medicine & Life Sciences